INTRODUCTION
The natural killer (NK)l cell system is believed to be an important effector limb of the immune surveillance network in animals and in man (1, 2) . The in vivo relevance of this in vitro phenomenon in man has been suggested by several lines of evidence, included in which is the selective impairment in NK function in the Chediak-Higashi syndrome (CHS) (3, 4) , a rare autosomal recessive disorder characterized by partial oculocutaneous albinism, severe recurrent pyogenic infections and abnormal lysosomal granules (5, 6) . Patients who survive the infectious complications of the disease often succumb to an aggressive lymphoproliferative disorder later in life (7) . The NK defect in these patients is not secondary to a lack of cells capable of recognizing and binding targets but appears to lie in the subsequent lytic process itself or in the recycling of NK cells.
To more precisely define the nature of the NK defect in CHS patients, our study was undertaken in which both a standard 51-chromium (51Cr) release microcytotoxicity assay and a single cell-in-agarose assay were used. Based on the methods of Grimm and Bon- ' Abbreviations used in this paper: CHS, Chediak-Higashi syndrome; 51Cr, 51-chromium; E/T, effector/target; FCS, fetal calf serum; IFN, interferon; Km, Michaelis constant; MRC, maximum recycling capacity; NK, natural killer; TBC, target binding cell; Vmax; maximum NK capacity; V, number of killed targets. avida (8) and Bradley and Bonavida (9) for the measurement of cytolytic T cell activity, Ullberg and Jondal (10) have recently demonstrated that the percent target cell binding, the percentage of target binding cells that go on the lysing the target (i.e., "active" NK cells), and the particular NK capacity (Vmax) of a given heterogeneous population of effector cells can be quantitated by simultaneously using both of these assays. With these determinations, it is possible to then estimate the percentage of "active" NK cells and the number of target cells killed by a given NK cell, that is, the recycling capacity of a single cytotoxic cell (10) . These methods have been extremely useful to date, particularly with regard to the enhancement of NK cell activity. For (5, 6) . At the time of this study, the patients were free of infection and were receiving no pharmacologic agents. Neither patient had any evidence of the progression of CHS into the lymphoproliferative disorder that characterizes this disease (7) . Control subjects consisted of age-and sex-matched normal adults.
Cell suspensions. Ficcll-Hypaque-isolated peripheral blood mononuclear cells were depleted of adherent cells by passage through nylon wool columns (14) (9) . Briefly, 2 X 105 effector cells and unlabeled target cells were mixed in a total volume of 0.2 ml RPMI 1640 with 15% FCS in a 3-cm3 round bottom tube. Using these conditions, no more than one lymphocyte is bound to any target cell, and therefore a true estimate of the frequency of effector-target cell conjugates can be obtained. At higher E/T ratios, several lymphocytes may bind to a single target cell, and therefore the percentage of conjugates cannot accurately be determined. Tubes were centrifuged at 500 g for 2 min and incubated at 370C for 10-20 min followed by gentle resuspension a single time with a pasteur pipette. To optimize for the number of effectortarget cell conjugates formed, this gentle resuspension technique was used because it has been demonstrated (9), and we have likewise observed that less avid effector-target cell conjugates can be disrupted by vigorous resuspension. By using this technique, we believe that we maximize the opportunity for these conjugates to remain intact. The cell mixture was then carefully added to 0.5 ml of 0.5% agarose in RPMI 1640 with 10 mM Hepes, which was precooled at room temperature from 470 to 390C. Cells were mixed in agarose with a pasteur pipette and then poured onto 60-mm Petri dishes (Falcon Labware, Div. Becton, Dickinson & Co., Oxnard, CA) that had been precoated with 0.5 cm3 of 0.5% agarose. After the cell mixture in agarose had solidified, 6 ml of RPMI 1640 with 15% FCS was added, and the plate was incubated as above for 4 h, except as noted. After incubation, the media was removed, and 2 ml of 0.1% trypan blue was added for 10 (10) have shown that Vmax can be calculated from the Lineweaver-Burk equation: RESULTS As described for these two patients (3, 4) , NK activity against K562 and Molt-4 in a standard 51Cr release assay was markedly deficient at all E/T ratios when compared with normal controls (Fig. 1) . Even with the assay time extended to 18 h, the cytotoxic function of CHS effector cells remained depressed (data not shown).
By using the 51Cr release assay and the single cellin-agarose assay simultaneously, we were able to determine and compare the Vmax, percent TBC, percent TBC with dead targets, percent active NK cells, and estimated MRC for normals and the CHS patients. As calculated from 51Cr release assay data, the CHS patients had significantly depres.sed values for Vmax against K562 and Molt-4 targets when compared with normal subjects (P < 0.005 for both patients for K562, P < 0.05 for both patients for Molt-4) ( Tables I and  II To determine the effects of in vitro IFN on the ki- (Fig. 2) . That is, for control and CHS subjects, a given level of either of these two cytotoxicity parameters was achieved earlier when effector cells were treated with IFN, indicative of an increased rate of killing.
DISCUSSION
This study has clearly demonstrated that the overall deficiency of NK activity in CHS patients is secondary to an inability of potentially cytotoxic lymphocytes capable of binding target cells to complete the lytic sequence. As described, the percentage of CHS TBC is comparable to normal values (3). Because these TBC populations contain lymphocytes with NK activity and because target binding is a prerequisite for lysis to occur, the lytic defect in CHS patients was not secondary to a failure of CHS NK cells to recognize or bind to susceptible target cells. However, within the population of CHS TBC there was a marked deficiency of active NK cells. These CHS active NK cells that were present, however, were not only capable of killing their bound targets but could repeat the entire lytic sequence (i.e., "recycle") in a manner comparable to normals. Thus, these active CHS effector cells appeared to be normal in all phases of the lytic event: target cell recognition and binding, lysis of the bound target cell, detachment from the dead target, and recycling.
In vitro IFN increased normal and CHS NK activity as determined by several different parameters. The overall Vmax of normal and CHS effector cells was increased by in vitro IFN. Because this value is directly calculated from 51Cr release microcytotoxicity values, this would be expected given the IFN-induced increase in 51Cr release from target cells. Similar findings for overall CHS NK activity have been reported using this same assay system (3).
Deficient Active NK Cells in the Chediak-Higashi Syndrome Effector cells were treated with media (control) or IFN (1,000 U/10 X 10' lymphocytes) for 30 min at 37°C before the assay.
In vitro IFN also increased the percentage of active NK cells indicative of IFN induction of previously nonlytic pre-NK cells to develop cytotoxic activity. Comparable findings with normal lymphocytes have been recently reported using similar single-cell cytotoxicity assays (11) (12) (13) 16) . This is reflected in the percentages of normal and CHS active NK cells in control and IFN-treated populations. Although the levels of CHS TBC with dead targets and active NK cells still remained depressed compared with normal values, the relative IFN-induced increase in these parameters for CHS effector cells was greater than that observed with normal lymphocytes. That is, the percentage of CHS TBC with dead targets doubled after IFN treatment, while values for the normal subject increased by approximately one-third (Table III) . Similarly, in vitro IFN increased the percentage of CHS active NK cells twofold, while increasing this parameter in the normal control by only 50% (Table III) .eR U)2. 
